Prospective analysis of pulmonary hypertension in extremely low birth weight infants
- PMID: 22311993
- PMCID: PMC3289526
- DOI: 10.1542/peds.2011-1827
Prospective analysis of pulmonary hypertension in extremely low birth weight infants
Abstract
Objectives: Pulmonary hypertension is associated with bronchopulmonary dysplasia in extremely low birth weight (ELBW) infants and contributes to morbidity and mortality. The objective was to determine the prevalence of pulmonary hypertension among ELBW infants by screening echocardiography and evaluate subsequent outcomes.
Methods: All ELBW infants admitted to a regional perinatal center were evaluated for pulmonary hypertension with echocardiography at 4 weeks of age and subsequently if clinical signs suggestive of right-sided heart failure or severe lung disease were evident. Management was at discretion of the clinician, and infants were evaluated until discharge from the hospital or pre-discharge death occurred.
Results: One hundred forty-five ELBW infants (birth weight: 755 ± 144 g; median gestational age: 26 weeks [interquartile range: 24-27]) were screened from December 2008 to February 2011. Overall, 26 (17.9%) were diagnosed with pulmonary hypertension at any time during hospitalization (birth weight: 665 ± 140 g; median gestational age: 26 weeks [interquartile range: 24-27]): 9 (6.2%) by initial screening (early pulmonary hypertension) and 17 (11.7%) who were identified later (late pulmonary hypertension). Infants with pulmonary hypertension were more likely to receive oxygen treatment on day 28 compared with those without pulmonary hypertension (96% vs 75%, P < .05). Of the 26 infants, 3 died (all in the late group because of cor pulmonale) before being discharged from the hospital.
Conclusions: Pulmonary hypertension is relatively common, affecting at least 1 in 6 ELBW infants, and persists to discharge in most survivors. Routine screening of ELBW infants with echocardiography at 4 weeks of age identifies only one-third of the infants diagnosed with pulmonary hypertension. Further research is required to determine optimal detection and intervention strategies.
Figures
Similar articles
-
Oxygen requirement as a screening tool for the detection of late pulmonary hypertension in extremely low birth weight infants.Cardiol Young. 2016 Mar;26(3):521-7. doi: 10.1017/S1047951115000608. Epub 2015 Jun 29. Cardiol Young. 2016. PMID: 26119883
-
The Impact of Pulmonary Hypertension in Preterm Infants with Severe Bronchopulmonary Dysplasia through 1 Year.J Pediatr. 2018 Dec;203:218-224.e3. doi: 10.1016/j.jpeds.2018.07.035. Epub 2018 Aug 29. J Pediatr. 2018. PMID: 30172426 Free PMC article.
-
An Echocardiographic Screening Program Helps to Identify Pulmonary Hypertension in Extremely Low Birthweight Infants with and without Bronchopulmonary Dysplasia: A Single-Center Experience.Neonatology. 2018;113(1):81-88. doi: 10.1159/000480694. Epub 2017 Nov 8. Neonatology. 2018. PMID: 29131022
-
Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.Neonatology. 2015;107(4):358-9. doi: 10.1159/000381132. Epub 2015 Jun 5. Neonatology. 2015. PMID: 26044104 Review.
-
Evaluation and Management of Pulmonary Hypertension in Children with Bronchopulmonary Dysplasia.J Pediatr. 2017 Sep;188:24-34.e1. doi: 10.1016/j.jpeds.2017.05.029. Epub 2017 Jun 20. J Pediatr. 2017. PMID: 28645441 Review. No abstract available.
Cited by
-
Comorbidities and Late Outcomes in Neonatal Pulmonary Hypertension.Clin Perinatol. 2024 Mar;51(1):271-289. doi: 10.1016/j.clp.2023.10.002. Epub 2023 Nov 7. Clin Perinatol. 2024. PMID: 38325946 Review.
-
Early Pulmonary Hypertension in Preterm Infants.Clin Perinatol. 2024 Mar;51(1):171-193. doi: 10.1016/j.clp.2023.11.005. Epub 2023 Dec 16. Clin Perinatol. 2024. PMID: 38325940 Review.
-
Assessing the role of tracheostomy placement in bronchopulmonary dysplasia with pulmonary hypertension.J Perinatol. 2024 Feb 5. doi: 10.1038/s41372-024-01881-y. Online ahead of print. J Perinatol. 2024. PMID: 38316933
-
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.JAMA Netw Open. 2023 Nov 1;6(11):e2345299. doi: 10.1001/jamanetworkopen.2023.45299. JAMA Netw Open. 2023. PMID: 38015504 Free PMC article.
-
Multi-dose enteral L-citrulline administration in premature infants at risk of developing pulmonary hypertension associated with bronchopulmonary dysplasia.J Perinatol. 2024 Feb;44(2):280-287. doi: 10.1038/s41372-023-01809-y. Epub 2023 Oct 31. J Perinatol. 2024. PMID: 37907796 Free PMC article. Clinical Trial.
References
-
- Subhedar NV. Recent advances in diagnosis and management of pulmonary hypertension in chronic lung disease. Acta Paediatr Suppl. 2004;93(444):29–32 - PubMed
-
- Gorenflo M, Vogel M, Obladen M. Pulmonary vascular changes in bronchopulmonary dysplasia: a clinicopathologic correlation in short- and long-term survivors. Pediatr Pathol. 1991;11(6):851–866 - PubMed
-
- Stenmark KR, Abman SH. Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia. Annu Rev Physiol. 2005;67:623–661 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
